The world, in perspective.

The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.

The WHO has started the first clinical trial of an Ebola vaccine for the Bundibugyo strain during the ongoing outbreak in the Democratic Republic of Congo. Read More: https://punchng.com/who-begins-ebola-vaccine-trial-in-dr-congo/

A clinical trial begins to test the safety, efficacy and immunogenicity of multiple vaccines.

Experts agree that vaccination is the best way to prevent serious illness and complications from influenza.

Moderna and Merck’s personalized mRNA vaccine for melanoma reduced the risk of cancer recurrence and death by 42% compared with standard treatment in a trial.

"Trust is slow to build and quick to lose," board chair Jack Leslie said.

Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful result for melanoma patients who underwent surgery.

A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a late-stage trial, making an approval expected

Beyond melanoma, scientists are studying cancer vaccines for glioblastoma, pancreatic cancer and more.

The scientists involved say the results could mark a turning point in cancer treatment, bringing personalised medicine a step closer.

A major breakthrough in fighting skin cancer has been announced, with an Australian-led trial developing a world first vaccine.

A world-first cancer vaccine has been shown to radically reduce the risk of melanoma recurrence and death.

<p>The Merck-Moderna mRNA cancer vaccine helps prevent cancer recurrence and death, the new results show</p>

Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.

Markers released top-line results today after previously reporting the trial succeeded.

Moderna released full data on its closely watched cancer vaccine developed with Merck.

The decried trial was canceled last week before police seized vaccine doses.

The Africa CDC says the Bundibugyo Ebola strain lacks an approved vaccine due to a lack of international interest because it is seen as an ‘African issue’. Read More: https://punchng.com/why-latest-ebola-strain-has-no-approved-vaccine-africa-cdc/

Andrea Shaw, 23, has said the 18-month-old twins became sick and died after receiving flu shots and routine childhood vaccinations.

Guinea-Bissau’s government has halted a controversial US-funded trial on the hepatitis B vaccine for newborns following international criticism over its et Read More: https://punchng.com/guinea-bissau-stops-controversial-us-funded-vaccine-trial-on-newborns/

Changes to federal hepatitis B vaccination recommendations could lead to more childhood infections, according to a new study published Monday.

<p>Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’</p><p>The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday.</p><p>It was “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schal

Guinea-Bissau police said hepatitis B vaccine doses were taken as part of an investigation.

<p>Police seize doses of hepatitis B vaccine from people at center of dispute over research on African newborns</p><p>Controversial vaccine researchers who have been praised by Robert F Kennedy Jr, the US Department of Health and Human Services (HHS) secretary, had their offices in Guinea-Bissau raided by judicial police, who seized doses of hepatitis B vacc